CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for First China Pharmaceutical Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

First China Pharmaceutical Group Inc
Number 504, West Ren Min Road
Phone: +86 85221381668p:+86 85221381668 KUNMING, YUN  650000  China Ticker: FCPGFCPG
On 6/3/2015, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of First China Pharmaceutical Group Inc for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.
Business Summary
First China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements.  The Company’s short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers’ primary distributor, supplying more than 80% of the pharmaceutical products they require.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201212/31/2011YesYes---

Industries
SIC Code Description
3663 Radio and television broadcasting and communications equipment
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Zhen Jiang J.Wang 53
President JingGong
Chief Financial Officer Yi Jia J.Li 41
4 additional Officers and Directors records available in full report.

Business Names
Business Name
E DISPATCH INC
FCPG
Kun Ming Xin Yuan Tang Pharmacies Co. Ltd.

General Information
Number of Employees: 98 (As of 12/31/2011)
Outstanding Shares: 59,664,480 (As of 9/30/2012)
Shareholders: 41
Stock Exchange: OTC
Federal Tax Id: 743232809


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023